We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01945775
Brief Title: A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) (EMBRACA)

First Submitted : September 11, 2013
First Submitted that Met QC Criteria : September 16, 2013
First Posted : September 19, 2013 (Estimate)

Last Update Submitted : November 20, 2017
Last Update Submitted that Met QC Criteria : November 20, 2017
Last Update Posted : November 22, 2017